image
Acurx Pharmaceuticals, Inc. ACXP
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.72
-2.82 %
$ 29.1 M
Market Cap
-1.52
P/E
BALANCE SHEET
7.71 M ASSETS
-17.78%
Growth Rates
1Year -17.78%
3Years 33.72%
5Years 0.00%
7Years 0.00%
10Years 0.00%
3.04 M LIABILITIES
47.57%
Growth Rates
1Year 47.57%
3Years 79.91%
5Years 0.00%
7Years 0.00%
10Years 0.00%
4.67 M EQUITY
-36.20%
Growth Rates
1Year -36.20%
3Years 19.99%
5Years 0.00%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Acurx Pharmaceuticals, Inc.
image
Current Assets 7.71 M
Cash & Short-Term Investments 7.47 M
Receivables 129 K
Other Current Assets 106 K
Non-Current Assets 0
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 0
Current Liabilities 3.04 M
Accounts Payable 3.81 K
Short-Term Debt 0
Other Current Liabilities 3.04 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
ASSETS
Cash & Cash Equivalents 7.5 9.1 13.0 3.2 2.5
Short Term Investments 0 0 0 0 0
Receivables 0.1 0 0 0 0
Inventory 0 0 0 0 0
Other Current Assets 0.1 0.3 0.3 48.6 K 48.1 K
Total Current Assets 7.7 9.4 13.3 3.2 2.5
PP&E 0 0 0 0 0
Intangible Assets 0 0 0 0 0
Goodwill 0 0 0 0 0
Long Term Investments 0 0 0 0 0
Other Long Term Assets 0 0 0 0 0
Other Assets 0 0.3 295.3 0 0
Total Assets 7.7 9.4 13.3 3.2 2.5
LIABILITIES
Accounts Payable 3.81 K 29.5 K 63.4 K 0 2.3 K
Short Term Debt 0 0 0 16.6 K 0
Other Current Liabilities 3.0 2.0 0.8 0.5 1.7
Total Current Liabilities 3.0 2.1 0.8 0.5 1.7
Long Term Debt 0 0 0 49.9 K 0
Deferred Tax Income 0 0 0 0 0
Other Liabilities 0 0 0 0 0
Total Liabilities 3.0 2.1 0.8 0.5 1.7
EQUITY
Common Stock 14.5 K 11.6 K 10.2 K 16.5 10.0
Retained Earnings (53.2) (38.6) (26.5) (13.8) (9.2)
Other Accumulative Comprehensive Income/Loss 0 (38.6) (26.5) (13.8) (9.2)
Total Equity 4.7 7.3 12.4 2.7 0.8
Total Liabilities and Equity 7.7 9.4 13.3 3.2 2.5
SHARES OUTSTANDING
Common Shares Outstanding 12.7 10.8 10.2 9.9 9.9